[Ivermectin as an adjunct in the treatment of refractory epilepsy].

CONCLUSION: Ivermectin has been useful as an adjuvant, achieving a significant decrease in seizures in this group of drug resistant patients.
PMID: 28929472 [PubMed - in process]

Source: Revista de Neurologia - September 22, 2017 Category: Neurology Authors: Diazgranados-Sanchez JA, Mejia-Fernandez JL, Chan-Guevara LS, Valencia-Artunduaga MH, Costa JL Tags: Rev Neurol Source Type: research